FDA-approved capivasertib triplet improves rPFS in PTEN-deficient mCSPC; learn dosing, key drug interactions, and managing diarrhea, hyperglycemia, and rash.
Julia Stevens, PharmD, BCOP
Advertisement
Articles by Julia Stevens, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Finerenone in Heart Failure: Evidence and Practice a Year Later
3
Pelacarsen, Ziltivekimab Miss CV End Points: What to Know
4
Breast Cancer Treatment Ends, But The Medication Questions Don’t
5